| Class 1 Device Recall VITEK 2 | |
Date Initiated by Firm | March 14, 2024 |
Date Posted | April 25, 2024 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-1464-2024 |
Recall Event ID |
94264 |
510(K)Number | K161217 |
Product Classification |
System, test, automated, antimicrobial susceptibility, short incubation - Product Code LON
|
Product | VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility):
a) AST-N334, REF 418984;
b) AST-GN95, REF 421982;
c) AST-GN99, REF 423102;
d) AST-N390, REF 423340;
e) AST-N391, REF 423341;
f) AST-N392, REF 423342;
g) AST-N395, REF 423491;
h) AST-N401, REF 423643;
i) AST-N402, REF 423644;
j) AST-N404, REF 423664;
k) AST-N802, REF 423706;
l) AST-N405, REF 423864;
m) AST-N417, REF 423880;
n) AST-N408, REF 423924;
o) AST-N409, REF 423925;
p) AST-N420, REF 424039;
q) AST-N423, REF 424042;
r) AST-N422, REF 424056;
s) AST-N436, REF 424440;
t) AST-N809, REF 424703;
u) AST-N806, REF 424709;
v) AST-N807, REF 424710;
w) AST-N808, REF 424711;
x) AST-N810, REF 424712;
y) AST-N812, REF 424721 |
Code Information |
a) AST-N334, REF 418984, UDI/DI 3573026490720, Lot/Serial Numbers: 7742790503, 7742805403, 7742828503, 7742830203;
b) AST-GN95, REF 421982, UDI/DI 3573026565923, Lot/Serial Numbers: 6852740103, 6852751503, 6852778503, 6852811503;
c) AST-GN99, REF 423102, UDI/DI 3573026608132, Lot/Serial Numbers: 6892721103, 6892727403, 6892740503, 6892740403, 6892743503, 6892761503, 6892770403, 6892790103, 6892799403, 6892799103, 6892810103, 6892818103, 6892831503;
d) AST-N390, REF 423340, UDI/DI 3573026612177, Lot/Serial Numbers: 1402832104, 1402761504;
e) AST-N391, REF 423341, UDI/DI 3573026612269, Lot/Serial Numbers: 1412831104, 1412754504;
f) AST-N392, REF 423342, UDI/DI 3573026612283, Lot/Serial Numbers: 1422819204;
g) AST-N395, REF 423491, UDI/DI 3573026615802, Lot/Serial Numbers: 1452725204;
h) AST-N401, REF 423643, UDI/DI 3573026616816, Lot/Serial Numbers: 1512776404, 1512789204, 1512811104, 1512831104, 1512720404, 1512729404, 1512729104, 1512748504, 1512754104, 1512785404;
i) AST-N402, REF 423644, UDI/DI 3573026616830, Lot/Serial Numbers: 1522720504, 1522733404;
j) AST-N404, REF 423664, UDI/DI 3573026617356, Lot/Serial Numbers: 1542819204;
k) AST-N802, REF 423706, UDI/DI 3573026617752, Lot/Serial Numbers: 0422750104, 0422763104, 0422764504, 0422782404, 0422820504, 0422820404;
l) AST-N405, REF 423864, UDI/DI 3573026621360, Lot/Serial Numbers: 1552757504, 1552792404, 1552800404, 1552820104, 1552733104, 1552741504, 1552757404;
m) AST-N417, REF 423880, UDI/DI 3573026621704, Lot/Serial Numbers: 0192763504, 0192819404;
n) AST-N408, REF 423924, UDI/DI 3573026622725, Lot/Serial Numbers: 1582810504, 1582820104, 1582734404, 1582742504, 1582764404, 1582782504;
o) AST-N409, REF 423925, UDI/DI 3573026622749, Lot/Serial Numbers: 1592811104, 1592746404;
p) AST-N420, REF 424039, UDI/DI 3573026625283, Lot/Serial Numbers: 0462810404;
q) AST-N423, REF 424042, UDI/DI 3573026625337, Lot/Serial Numbers: 0502750404, 0502825504;
r) AST-N422, REF 424056, UDI/DI 3573026625610, Lot/Serial Numbers: 0482819504;
s) AST-N436, REF 424440, UDI/DI 3573026631666, Lot/Serial Numbers: 0672734104, 0672754104;
t) AST-N809, REF 424703, UDI/DI 3573026635978, Lot/Serial Numbers: 0962799404;
u) AST-N806, REF 424709, UDI/DI 3573026636067, Lot/Serial Numbers: 0932729404;
v) AST-N807, REF 424710, UDI/DI 3573026636081, Lot/Serial Numbers: 0942723404;
w) AST-N808, REF 424711, UDI/DI 3573026636104, Lot/Serial Numbers: 0952758104;
x) AST-N810, REF 424712, UDI/DI 3573026636128, Lot/Serial Numbers: 0972729504;
y) AST-N812, REF 424721, UDI/DI 3573026636296, Lot/Serial Numbers: 0992777104, 0992776504, 0992821404
|
Recalling Firm/ Manufacturer |
Biomerieux Inc 595 Anglum Rd Hazelwood MO 63042-2320
|
For Additional Information Contact | bioMerieux Customer Service Center 800-682-2666 |
Manufacturer Reason for Recall | Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for isolates that have a result of MIC=0.5, 1, 2. |
FDA Determined Cause 2 | Employee error |
Action | BioMerieux issued an URGENT FIELD SAFETY NOTICE to its consignees on 03/14/2024 via email. The notice explained the issue, impact to patient, and provided the consignee (user) with alternate testing methods.
BioMerieux issued another URGENT FIELD SAFETY NOTICE dated 07MAY2024 to its consignees on May 9, 2024, via email. This letter includes the statement, "however, no results for the Ceftriaxone (cro02n) should be reported outside the lab." |
Quantity in Commerce | 49215 units |
Distribution | Worldwide |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database | 510(K)s with Product Code = LON
|
|
|
|